1. Home
  2. MSBI vs ALLO Comparison

MSBI vs ALLO Comparison

Compare MSBI & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Midland States Bancorp Inc.

MSBI

Midland States Bancorp Inc.

HOLD

Current Price

$23.99

Market Cap

466.7M

Sector

Finance

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$3.14

Market Cap

539.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSBI
ALLO
Founded
1881
2017
Country
United States
United States
Employees
861
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
466.7M
539.4M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MSBI
ALLO
Price
$23.99
$3.14
Analyst Decision
Hold
Strong Buy
Analyst Count
3
12
Target Price
$22.83
$8.73
AVG Volume (30 Days)
115.3K
7.6M
Earning Date
04-23-2026
05-12-2026
Dividend Yield
5.34%
N/A
EPS Growth
N/A
34.09
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.41
N/A
Revenue Next Year
$2.07
$144,130.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.24
$0.86
52 Week High
$24.72
$4.46

Technical Indicators

Market Signals
Indicator
MSBI
ALLO
Relative Strength Index (RSI) 65.50 66.63
Support Level $20.81 $1.10
Resistance Level $24.41 N/A
Average True Range (ATR) 0.61 0.30
MACD 0.28 0.06
Stochastic Oscillator 77.86 43.83

Price Performance

Historical Comparison
MSBI
ALLO

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: